Drug Profile
P 16
Alternative Names: P-16; P16 -13therapeutics; Peptide P-16Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Unknown
- Developer 13therapeutics
- Class Anti-inflammatories; Peptides
- Mechanism of Action Toll-like receptor 4 antagonists; Toll-like receptor 9 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Atherosclerosis; Inflammatory bowel diseases
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Atherosclerosis in USA
- 28 Aug 2020 No recent reports of development identified for research development in Inflammatory-bowel-diseases in USA
- 20 Jul 2016 Early research in Atherosclerosis in USA (unspecified route)